Effect of aripiprazole on cognition in the treatment of patients with schizophrenia.

Riedel, M; Spellmann, I; Schennach-Wolff, R; Musil, R; Dehning, S; Cerovecki, A; Opgen-Rhein, M; Matz, J; Seemüller, F; Obermeier, M; Severus, E; Engel, R R; Müller, N; Möller, H-J

Riedel, M; Spellmann, I; Schennach-Wolff, R; Musil, R; Dehning, S; Cerovecki, A; Opgen-Rhein, M; Matz, J; Seemüller, F; Obermeier, M; Severus, E; Engel, R R; Müller, N; Möller, H-J.

Affiliation

Riedel M; Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University, Munich, Germany.

Pharmacopsychiatry ; 43(2): 50-7, 2010 Mar.

Article in En | MEDLINE | ID: mdl-20336597

Subject(s)

Antipsychotic Agents/therapeutic use; Cognition/drug effects; Piperazines/therapeutic use; Quinolones/therapeutic use; Schizophrenia/drug therapy; Adult; Antipsychotic Agents/adverse effects; Aripiprazole; Attention/drug effects; Humans; Inpatients; Memory/drug effects; Neuropsychological Tests; Piperazines/adverse effects; Psychiatric Status Rating Scales; Quinolones/adverse effects; Reaction Time/drug effects; Time Factors; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Schizophrenia / Antipsychotic Agents / Cognition / Quinolones Limits: Adult / Humans Language: En Journal: Pharmacopsychiatry Year: 2010 Document type: Article Affiliation country: Germany Country of publication: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google